240例上消化道黏膜下肿瘤内镜治疗的疗效及并发症评估

doi:10.6040/j.issn.1671-7554.0.2020.1446

摘要/Abstract

摘要： 目的探究上消化道黏膜下肿瘤(SMT)患者的临床特点及影响SMT患者术后并发症及住院花费的临床因素。方法收集2012年1月至2019年6月于山东大学附属山东省立医院就诊的240例SMT患者的临床资料,统计分析入组SMT患者的临床特点、病理类型、治疗方案及治疗效果。结果本研究共入组240例SMT患者,其中男性101例(42.1%),女性139例(57.9%);平均发病年龄为54.19岁; 通过超声胃镜确定SMT大小、部位及起源, 食管57例(23.8%)、胃食管结合部位 7例(7.1%)、胃163例(67.9%)、十二指肠3例(1.3%),SMT平均大小为1.12 cm,153例(71.5%)起源于固有肌层,37例(17.7%)起源于黏膜肌层,24例(11.2%)起源于黏膜下层; 69例(28.8%)患者给予内镜黏膜下剥离术(ESD)治疗,117例(48.8%)患者给予内镜黏膜下挖除术(ESE),28例(11.7%)患者给予内镜全层切除术(EFR),26例(10.7%)患者给予经黏膜下隧道内镜肿瘤切除术(STER);病理类型以平滑肌瘤(117,49.2%)和间质瘤(78,32.8%)为主。237例(98.8%)患者于内镜下成功治疗,整块切除率达到90.4%(217/240)。患者的平均手术时间为58.37 min,平均住院10.07 d,平均住院花费35 830.3元。术后共有17例(7.1%)患者出现并发症,其中10例(4.2%)患者给予保守治疗后症状缓解,7例(2.9%)患者给予积极干预后缓解,无死亡或远期并发症病例。手术时长≥55 min、SMT≥2 cm为SMT患者术后发生并发症的高危因素,手术时间≥55 min、SMT≥2 cm、未能整块切除及使用内镜吻合夹系统OTSC是住院花费的正性影响因素。结论内镜下切除是治疗SMT安全有效的方式,早期发现、早期治疗、缩短手术时间是降低SMT患者术后并发症发生率及减少患者住院花费的有效途径。

关键词: 黏膜下肿瘤, 消化内镜, 临床特点, 疗效, 并发症

Abstract: Objective To explore the clinical characteristics of upper gastrointestinal submucosal tumors(SMT)and clinical factors affecting postoperative complications and hospitalization costs of SMT patients. Methods The clinical data of 240 SMT patients treated in Shandong Provincial Hospital during Jan. 2012 and Jun. 2019 were collected, and the clinical characteristics, pathological types, treatment modalities and therapeutic effects were analyzed. Results The patients included 101 male(42.1%)and 139 female(57.9%), mean age 54.19 years, and mean size of SMT 1.12 cm. The tumors were located in the esophagus in 57 cases(23.8%), in the gastroesophageal junction in 17 cases(7.1%), in the stomach in 163 cases(67.9%), and in the duodenum in 3 cases(1.3%). Endoscopic submucosal dissection(ESD)was performed in 69 patients(28.8%), endoscopic submucosal excavation(ESE)in 117 patients(48.8%), endoscopic full-thickness resection(EFR)in 28 patients(11.7%), and submucosal tunneling endoscopic resection(STER)in 26 patients(10.7%). The main pathological types were leiomyoma(117, 49.2%)and stromal tumor(78, 32.8%). Altogether 237 patients(98.8%)were successfully treated, with 90.4%(217/240)en bloc resection rate. The mean operation time was 58.37 minutes, hospital stay 10.07 days, and hospitalization costs 35 830.3 yuan. Complications were observed in 17 patients(7.1%), 10(4.2%)of whom relieved after conservative treatment and 7(2.9%)received active interventions such as endoscopic hemostasis, gastrointestinal decompression and puncture drainage. No death or long-term complications occurred. Operation time ≥55 min and SMT≥2 cm were the risk factors of postoperative complications; meanwhile, operation time ≥55 min, SMT≥2 cm, failure of en bloc resection and use of OTSC increased hospitalization costs. Conclusion Endoscopic resection is a safe and effective treatment modality of SMT. Early detection, early treatment and short operation time are effective ways to reduce the incidence of postoperative complications and hospitalization costs.

Key words: Submucosal tumors, Endoscope, Clinical characteristics, Efficacy, Complications

中图分类号:

R735

罗应舒,李宾,许昌芹,姜军梅,许洪伟. 240例上消化道黏膜下肿瘤内镜治疗的疗效及并发症评估[J]. 山东大学学报 (医学版), 2021, 59(3): 74-80.

LUO Yingshu, LI Bin, XU Changqin, JIANG Junmei, XU Hongwei. Evaluation of the efficacy and complications of endoscopic treatment of 240 cases of upper gastrointestinal submucosal tumors[J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 74-80.

参考文献

[1] Nishida T, Kawai N, Yamaguchi S, et al. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors [J]. Dig Endosc, 2013, 25(5): 479-489.
[2] Papanikolaou IS, Triantafyllou K, Kourikou A, et al. Endoscopic ultrasonography for gastric submucosal lesions [J]. World J Gastrointest Endosc, 2011, 3(5): 86-94.
[3] Longcroft-Wheaton G, Bhandari P. Endoscopic resection of submucosal tumors [J]. Expert Rev Gastroenterol Hepatol, 2015, 9(5): 659-669.
[4] Polkowski M. Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors [J]. Endoscopy, 2005, 37(7): 635-645.
[5] Nishida T, Goto O, Raut C P, et al. Diagnostic and treatment strategy for small gastrointestinal stromal tumors [J]. Cancer, 2016, 122(20): 3110-3118.
[6] Abe N, Takeuchi H, Ohki A, et al. Comparison between endoscopic and laparoscopic removal of gastric submucosal tumor [J]. Dig Endosc, 2018, Suppl 1:7-16. doi: 10.1111/den.13010.
[7] Chai N, Du C, Gao Y, et al. Comparison between submucosal tunneling endoscopic resection and video-assisted thoracoscopic enucleation for esophageal submucosal tumors originating from the muscularis propria layer: a randomized controlled trial [J]. Surg Endosc, 2018, 32(7): 3364-3372.
[8] Kikuchi S, Nishizaki M, Kuroda S, et al. Nonexposure laparoscopic and endoscopic cooperative surgery(closed laparoscopic and endoscopic cooperative surgery)for gastric submucosal tumor [J]. Gastric Cancer, 2017, 20(3): 553-557.
[9] Onimaru M, Inoue H, Bechara R, et al. Clinical outcomes of per-oral endoscopic tumor resection for submucosal tumors in the esophagus and gastric cardia [J]. Dig Endosc, 2020, 32(3): 328-336.
[10] Nabi Z, Ramchandani M, Chavan R, et al. Endoscopic dissection of an esophageal submucosal tumor using a novel bipolar radiofrequency device [J]. Endoscopy, 2020, 52(7): E257-E258.
[11] Standards of Practice C, Faulx AL, Kothari S, et al. The role of endoscopy in subepithelial lesions of the GI tract [J]. Gastrointest Endosc, 2017, 85(6): 1117-1132.
[12] 沈琳, 曹晖, 秦叔逵, 等. 中国胃肠间质瘤诊断治疗共识[J]. 肿瘤综合治疗电子杂志, 2018, 4(1): 31-43. SHEN Lin, CAO Hui, QIN Shuikui, et al. Chinese consensus on diagnosis and treatment of gastrointestinal stromal tumors [J]. Journal of Multidisciplinary Cancer Management, 2018, 4(1): 31-43.
[13] Zhou P, Zhong Y, Li Q. Chinese consensus on endoscopic diagnosis and management of gastrointestinal submucosal tumor(version 2018)[J]. Zhonghua Wei Chang Wai Ke Za ZHi, 2018, 21(8): 841-852.
[14] Li B, Chen T, Qi ZP, et al. Efficacy and safety of endoscopic resection for small submucosal tumors originating from the muscularis propria layer in the gastric fundus [J]. Surg Endosc, 2019, 33(8): 2553-2561.
[15] Joo MK, Park JJ, Kim H, et al. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract [J]. Gastrointest Endosc, 2016, 83(2): 318-326.
[16] Yang YT, Shen N, Ao F, et al. Diagnostic value of contrast-enhanced harmonic endoscopic ultrasonography in predicting the malignancy potential of submucosal tumors: a systematic review and meta-analysis [J]. Surg Endosc, 2020, 34(9): 3754-3765.
[17] 李琛, 谭玉勇, 乐梅先, 等. 内镜黏膜下剥离术治疗十二指肠病变的临床疗效分析[J]. 中华消化内镜杂志, 2010, 37(3): 190-4. LI Chen, TAN Yuyong, LE Meixian, et al. Efficacy of endoscopic submucosal dissection for duodenal lesions [J]. Chinese Journal of Digestive Endoscopy, 2010, 37(3): 190-194.
[18] Xiu H, Zhao CY, Liu FG, et al. Comparing about three types of endoscopic therapy methods for upper gastrointestinal submucosal tumors originating from the muscularis propria layer [J]. Scand J Gastroenterol, 2019, 54(12): 1481-1486.
[19] Cai MY, Martin Carreras-Presas F, Zhou PH. Endoscopic full-thickness resection for gastrointestinal submucosal tumors [J]. Dig Endosc, 2018(Suppl 1): 17-24. doi: 10.1111/den.13003.
[20] Xu HW, Zhao Q, Yu SX, et al. Comparison of different endoscopic resection techniques for submucosal tumors originating from muscularis propria at the esophagogastric junction [J]. BMC Gastroenterol, 2019, 19(1): 174.
[21] Du C, Chai N, Linghu E, et al. Treatment of cardial submucosal tumors originating from the muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation [J]. Surg Endosc, 2018, 32(11): 4543-4551.
[22] Lv XH, Wang CH, Xie Y. Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors: a systematic review and meta-analysis [J]. Surg Endosc, 2017, 31(1): 49-63.
[23] Chen T, Zhang C, Yao LQ, et al. Management of the complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors [J]. Endoscopy, 2016, 48(2): 149-155.

相关文章 15

[1]	董恣豪,刘喆,王浩,于辰曦,杨光,丰浩田. 髋关节镜下关节囊不同切开方式早期术后并发症[J]. 山东大学学报 (医学版), 2026, 64(5): 83-87.
[2]	王兴山,张浩天,张云峰,周一新. 旋转铰链膝在复杂初次膝关节置换中的应用及临床疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 51-57.
[3]	罗淇,王霞,姜孟. 脑功能网络分析在失语症诊疗中的应用:病理机制分析、临床诊断与疗效评价[J]. 山东大学学报 (医学版), 2025, 63(8): 111-126.
[4]	苗壮,刘培来. 双柱活动平台单髁假体治疗膝关节前内侧骨关节炎的中期疗效[J]. 山东大学学报 (医学版), 2025, 63(7): 62-67.
[5]	国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32.
[6]	王建旭,彭晓辉,丰浩田,安森博,董恣豪,黄子帅,刘喆,杨光. 应用内支撑技术辅助膝关节前交叉韧带全内重建术近期疗效观察[J]. 山东大学学报 (医学版), 2025, 63(3): 22-27.
[7]	贾振存,吴晨睿,赵德龙,朱可嘉,丁森泰. 八宝丹胶囊联合米拉贝隆治疗女性膀胱过度活动症的有效性与安全性[J]. 山东大学学报 (医学版), 2025, 63(10): 72-79.
[8]	史潇兮,辛世杰. 腹主动脉瘤的开放手术[J]. 山东大学学报 (医学版), 2024, 62(9): 26-29.
[9]	孙晓丹,杨创. 多黏菌素B治疗ICU耐碳青霉烯类革兰阴性杆菌感染患者的效果[J]. 山东大学学报 (医学版), 2024, 62(7): 72-77.
[10]	武姗姗,汪树仁,赵同航,张宗旺. 消化内镜手术术后疼痛分析:回顾性队列研究[J]. 山东大学学报 (医学版), 2024, 62(2): 42-50.
[11]	王瑞霞,苏童,赵淑磊. 内镜逆行性胆胰管造影术罕见并发症-胆道支架无法拔除1例[J]. 山东大学学报 (医学版), 2024, 62(2): 113-115.
[12]	冯绪强,高萍,孙超,陶琳,闫根全,冷冰. 替加环素治疗感染性疾病临床疗效及影响因素[J]. 山东大学学报 (医学版), 2024, 62(12): 11-20.
[13]	李红梅,蔡敏,周立,姚欣雨,刘力. 不同膈肌超声功能指标在腹部手术后肺部并发症中的预测价值[J]. 山东大学学报 (医学版), 2024, 62(10): 115-124.
[14]	徐荣坤,王连雷,原所茂,田永昊,刘新宇. 腰椎术中腹主动脉损伤1例并文献复习[J]. 山东大学学报 (医学版), 2023, 61(6): 121-124.
[15]	吴磊丽,蔡华丽,孙德胜,魏蔚霞. 超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿的疗效[J]. 山东大学学报 (医学版), 2023, 61(6): 65-69.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed